An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme.
Oct 2009 - Mol. Cancer Ther.; 8(10):1538-8514 [PMID:19825799]
[Sampson JH] [Archer GE] [Mitchell DA] [Heimberger AB] [Herndon JE] [Lally-Goss D] [McGehee-Norman S] [Paolino A] [Reardon DA] [Friedman AH] [Friedman HS] [Bigner DD]